New York State Common Retirement Fund’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

New York State Common Retirement Fund’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,160	Closed	-$106K	–	3322
2019 Q1	$106K	Hold	3,160	–	–	﹤0.01%	2936
2018 Q4	$92K	Hold	3,160	–	–	﹤0.01%	2981
2018 Q3	$195K	Hold	3,160	–	–	﹤0.01%	2839
2018 Q2	$233K	Buy	3,160 +360	+13%	+$28.1K	﹤0.01%	2811
2018 Q1	$184K	Hold	2,800	–	–	﹤0.01%	2768
2017 Q4	$235K	Hold	2,800	–	–	﹤0.01%	2686
2017 Q3	$323K	Hold	2,800	–	–	﹤0.01%	2574
2017 Q2	$327K	Buy	2,800 +660	+31%	+$81.9K	﹤0.01%	2628
2017 Q1	$264K	Hold	2,140	–	–	﹤0.01%	2662
2016 Q4	$291K	Hold	2,140	–	–	﹤0.01%	2628
2016 Q3	$426K	Hold	2,140	–	–	﹤0.01%	2389
2016 Q2	$277K	Buy	2,140 +1,390	+185%	+$155K	﹤0.01%	2565
2016 Q1	$70K	Hold	750	–	–	﹤0.01%	3006
2015 Q4	$152K	Hold	750	–	–	﹤0.01%	2890
2015 Q3	$109K	Sell	750 -121	-14%	-$22.2K	﹤0.01%	3012
2015 Q2	$185K	Buy	+871	New	+$214K	﹤0.01%	2944

Other funds holding BLCM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

New York State Common Retirement Fund's BLCM Position: Q2 2019 in Review

New York State Common Retirement Fund sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2019, closing a stake of 3,160 shares — an estimated $106K sold.

New York State Common Retirement Fund first reported a position in BLCM in Q2 2015 and held it in 16 quarters. The position peaked at $426K in Q3 2016. 79 funds tracked by Wall St. Rank hold BLCM as of Q2 2019.

New York State Common Retirement Fund reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
New York State Common Retirement Fund sold 3,160 Bellicum Pharmaceuticals, Inc. shares in Q2 2019, an estimated $106K.
New York State Common Retirement Fund first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2015 and held it in 16 quarters.
New York State Common Retirement Fund's Bellicum Pharmaceuticals, Inc. position peaked at $426K in Q3 2016.
79 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2019.

Based on New York State Common Retirement Fund's 13F filing for Q2 2019, filed 9 Aug 2019.